President Trump announced on Nov. 6 that the manufacturers of popular weight-loss drugs have agreed to reduce prices that Americans pay. The announcement follows Trump’s executive order from May when ...

Danish obesity drug maker Novo Nordisk's new CEO risks being on the losing side of a damaging price war as "unprecedented" ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Novo Nordisk has cut the price of its blockbuster weight-loss drug Wegovy by up to 33% in India, a Reuters report said on Tuesday. The move aimed at expanding access and defending market share amid ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Novo Nordisk just addressed a problem that has prevented some from taking these drugs. Investors generally buy pharmaceutical stocks to add an element of safety to their portfolios. People need their ...

How Democrats plan to pivot to midterms, a White House deal lowers prices of weight-loss drugs, and more Length: Long Speed: 1.0x President Trump announced on Nov. 6 that the manufacturers of popular ...